Genmab A/S Stock

Genmab A/S Diluted EPS

The Diluted Earnings per Share of Genmab A/S (GMAB.CO) as of Jul 28, 2026 is 15.36 USD. In the previous year, Diluted Earnings per Share was 17.60 USD — a change of -12.72% (lower).

Diluted EPS

15.36USD

YoY

-12.72%

Last updated:

Diluted Earnings per Share of Genmab A/S is 2026 15.36 USD. Diluted Earnings per Share of Genmab A/S was 2025 17.60 USD. It decreases by -12.72% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Diluted Earnings per Share of Genmab A/S is 15.36 USD in 2026.

Access this data via the Eulerpool API

Income Statement — Genmab A/S

All Key Metrics — Genmab A/S